🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

The morning catch up: ASX down, US markets up but weak Chinese data new source of concern

Published 18/07/2023, 09:50 am
© Reuters The morning catch up: ASX down, US markets up but weak Chinese data new source of concern
UK100
-
DJI
-
F
-
AAPL
-
MS
-
HG
-
LCO
-
TSLA
-
IXIC
-
FTEU3
-

ASX futures were pointing down 13 points or 0.2% to 7,246 this morning, but it wasn’t doom and gloom on Wall Street overnight.

US shares rallied as earnings guidance predicted a strong season, against the backdrop of expectations for a more dovish approach to rates from the Federal Reserve.

Investors were instead puzzling over the emerging issue of a Chinese slowdown, about which more later.

US markets take a breather ... for now

At the close of trade, the Dow Jones index was up 76 points or 0.2%, the S&P 500 index moved 0.4% and the Nasdaq index gained 131 points or 0.9%.

Tesla (NASDAQ:TSLA) was up 3.2% on news it has built its first Cybertruck, after a lag of two years, while notional competitor Ford Motor (NYSE:F) shares took a 5.9% dive after it cut the price of its electric F-150 Lightning trucks.

Apple (NASDAQ:AAPL) was up 1.7% after a good report card from Morgan Stanley (NYSE:NYSE:MS) that raised its target price.

And the box office still matters – the new ‘Mission: Impossible’ film’s lacklustre performance saw shares in Paramount Global tumble 3.8%.

European sharemarkets fell yesterday on the back of weak economic data from China, with luxury brands such as Richemont (-10.4%), LVMH, Hermes and Salvatore Ferragamo taking the biggest hit.

On a sector basis, the personal and household goods index lost the most, dropping 2.6%.

The continent-wide FTSEurofirst 300 index slid 0.6%, while the UK FTSE 100 index lost 0.4% with shares of industrial miners down by 2.6%.

China slowdown

Data out of China this week shows that consumer spending and business confidence are in trouble.

There was momentum earlier in the year as the economy bounced back following late and harsh lockdowns in large cities, but that seems to have run out of puff.

While the US remains very exposed to any Chinese economic pain, Treasury secretary Janet Yellen waved away the possibility that the slowdown in China would cause a US recession:

“Many countries do depend on strong Chinese growth to promote growth in their own economies, particularly countries in Asia, and slow growth in China can have some negative spillovers for the United States.

“Growth has slowed but our labour market continues to be quite strong. I don’t expect a recession.”

Currencies, crude and commodities

Global currencies were mixed against the US dollar overnight.

The Euro fell from US$1.1248 to US$1.1203 and was near US$1.1235 at the US close, while our dollar rose from 67.88 US cents to 68.28 US cents and was near 68.15 US cents at the end of yesterday.

The Yen dipped from 138.01 per US dollar to JPY139.38 and was near JPY138.70 at the US close.

The weak Chinese data affected global oil prices in the world’s second-biggest consumer of the commodity – they dropped by 1.7% yesterday.

A partial restart of halted Libyan output also pressured prices.

Brent crude fell by US$1.37 or 1.7% to US$78.50 a barrel, while US Nymex crude fell US$1.27 or 1.7% to US$74.15 a barrel.

The Chinese figures affected base metal prices too, which crashed on Monday. Copper futures fell by 2.3%, while aluminium futures slid 1.3%.

What’s happening in small caps?

The S&P/ASX Small Ordinaries closed at 2,891.23 yesterday, down 0.42% on the previous day.

Making news this morning, which you can read more about throughout the day with Proactive are:

  • Kinetiko Energy Ltd (ASX:KKO, OTC:KKOEF) has released a progress report on its onshore gas exploration and production development activities.
  • OzAurum Resources Ltd (ASX:OZM) has welcomed an initial combined mineral resource estimate (MRE) for the Mulgabbie North Gold Project.
  • Alicanto Minerals Ltd (ASX:AQI) says a geological review of Falun data has identified significant brownfield targets for testing in upcoming diamond drilling program.
  • Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has engaged Fortrea to manage its FDA IND opening Phase 2/3 clinical trial investigating IHL-42X for the treatment of obstructive sleep apnoea.
  • Critical minerals explorer Stelar Metals Ltd (ASX:SLB) has kicked off on-ground field activities at its newly acquired Trident Lithium Project at Broken Hill.
  • Read more on Proactive Investors AU

    Disclaimer

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.